High agreement of routine cytopathology and immunocytochemistry in canine lymphomas

R Sapierzyński1, I Dolka, M Fabisiak

  • 1Department of Pathology and Veterinary Diagnostic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Nowoursynowska 159c, 02-766 Warsaw, Poland. rafal_sapierzynski@sggw.pl

Insights

Routine cytopathology and immunocytochemistry (IC) show high concordance (90%) for canine lymphoma immunophenotyping. This combination aids precise diagnosis, treatment planning, and prognosis, reducing the need for invasive biopsies.

Area of Science:

  • Veterinary Pathology
  • Immunology
  • Oncology

Background:

  • Accurate immunophenotyping is crucial for diagnosing canine lymphoma.
  • Routine cytopathology using Giemsa stain is a common diagnostic method.
  • Immunocytochemistry (IC) provides specific antigen detection for cell lineage confirmation.

Purpose of the Study:

  • To compare the concordance between routine cytopathology (Giemsa stain) and immunocytochemistry (CD3, CD79 alpha) for canine lymphoma immunophenotyping.
  • To evaluate the diagnostic accuracy of combining these methods.
  • To assess the clinical utility of this combined approach in canine lymphoma cases.

Main Methods:

  • Cytological samples from 70 canine lymphomas were analyzed.
  • Samples were stained with Giemsa solution for routine cytopathology.
  • Immunocytochemistry was performed to detect CD3 and CD79 alpha antigens.
  • Cohen's kappa coefficient was calculated to measure concordance.

Main Results:

  • Immunocytochemistry classified 42 lymphomas as B cell and 28 as T cell.
  • Full accordance between cytopathology and IC was achieved in 63 out of 70 cases (90%).
  • The combined approach yielded precise diagnoses in 90% of cases.

Conclusions:

  • Routine cytopathology with Giemsa stain is a valuable tool for preliminary lymphoma immunophenotyping in dogs.
  • Combining routine cytopathology with immunocytochemistry offers high diagnostic accuracy (90%) for canine lymphomas.
  • This integrated diagnostic strategy simplifies treatment planning and prognosis determination while minimizing invasive procedures and associated costs.